Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-12

Clinical Trial Update: Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing safety of switching from lamivudine to adefovir dipivoxil versus overlapping lamivudine and adefovir before adefovir dipivoxil …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adefovir Dipivoxil (Adefovir dipivoxil)
  • Lamivudine (lamivudine)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED